ICON plc ICLR is well-poised to grow in the upcoming quarters, driven by its strategic additions. Leveraging AI and technology advancements, the company is optimizing clinical delivery and has seen ...

ICON Public Limited (ICLR) posted its worst intraday stock performance in decades on Thursday after the company announced that it is withdrawing its previously issued 2025 financial guidance amid an ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Meanwhile, Evercore has suspended its stock rating for ICON amid the ongoing investigation. Both Jefferies and Truist Securities have maintained their Hold ratings on ICON, with price targets set at ...

Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...

Investing.com -- ICON plc (NASDAQ:ICLR) stock plummeted 32% on Thursday after the clinical research organization announced an internal accounting investigation and delayed its fourth quarter and full ...

Icon's stock plummeted about 40% on Feb. 12, as the firm announced an accounting investigation initiated by the Audit Committee of Icon's board of directors. Preliminary results indicate the company's ...

Investing.com - TD Cowen upgraded ICON plc (NASDAQ:ICLR) to Buy from Hold on Tuesday, setting a price target of $120. The clinical research organization’s stock is currently trading at $88.62, with ...